Literature DB >> 31930492

The meninges enhance leukaemia survival in cerebral spinal fluid.

Patrick Basile1,2, Leslie M Jonart1,2, Maryam Ebadi1,2, Kimberly Johnson1,2, Morgan Kerfeld1,2, Peter M Gordon1,2.   

Abstract

Central nervous system (CNS) relapse is a common cause of treatment failure in patients with acute lymphoblastic leukaemia (ALL) despite current CNS-directed therapies that are also associated with significant short- and long-term toxicities. Herein, we showed that leukaemia cells exhibit decreased proliferation, elevated reactive oxygen species (ROS) and increased cell death in cerebral spinal fluid (CSF) both in vitro and in vivo. However, interactions between leukaemia and meningeal cells mitigated these adverse effects. This work expands our understanding of the pathophysiology of CNS leukaemia and suggests novel therapeutic approaches for more effectively targeting leukaemia cells in the CNS.
© 2020 British Society for Haematology and John Wiley & Sons Ltd.

Entities:  

Keywords:  acute lymphpoblastic leukaemia; cell adhesion; cell death; central nervous system; cerebral spinal fluid

Mesh:

Year:  2020        PMID: 31930492      PMCID: PMC7192757          DOI: 10.1111/bjh.16270

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  15 in total

1.  iBH3: simple, fixable BH3 profiling to determine apoptotic priming in primary tissue by flow cytometry.

Authors:  Jeremy Ryan; Joan Montero; James Rocco; Anthony Letai
Journal:  Biol Chem       Date:  2016-07-01       Impact factor: 3.915

Review 2.  Mitochondria as emerging targets for therapies against T cell acute lymphoblastic leukemia.

Authors:  Miguel Olivas-Aguirre; Igor Pottosin; Oxana Dobrovinskaya
Journal:  J Leukoc Biol       Date:  2019-01-30       Impact factor: 4.962

3.  Vincristine induced apoptosis in acute lymphoblastic leukaemia cells: a mitochondrial controlled pathway regulated by reactive oxygen species?

Authors:  E Groninger; G J Meeuwsen-De Boer; S S N De Graaf; W A Kamps; E S J M De Bont
Journal:  Int J Oncol       Date:  2002-12       Impact factor: 5.650

Review 4.  Advances in understanding the pathogenesis of CNS acute lymphoblastic leukaemia and potential for therapy.

Authors:  Liron Frishman-Levy; Shai Izraeli
Journal:  Br J Haematol       Date:  2016-10-21       Impact factor: 6.998

Review 5.  Histopathology of CNS leukemia and complications of therapy.

Authors:  R A Price
Journal:  Am J Pediatr Hematol Oncol       Date:  1979

Review 6.  A balanced view of the cerebrospinal fluid composition and functions: Focus on adult humans.

Authors:  Reynold Spector; S Robert Snodgrass; Conrad E Johanson
Journal:  Exp Neurol       Date:  2015-08-04       Impact factor: 5.330

Review 7.  Current management and challenges of malignant disease in the CNS in paediatric leukaemia.

Authors:  Ching-Hon Pui; Scott C Howard
Journal:  Lancet Oncol       Date:  2008-03       Impact factor: 41.316

Review 8.  Human serum albumin and its relation with oxidative stress.

Authors:  Mustafa Erinç Sitar; Seval Aydin; Ufuk Cakatay
Journal:  Clin Lab       Date:  2013       Impact factor: 1.138

9.  High throughput sequencing in acute lymphoblastic leukemia reveals clonal architecture of central nervous system and bone marrow compartments.

Authors:  Jack Bartram; Nick Goulden; Gary Wright; Stuart Adams; Tony Brooks; Darren Edwards; Sarah Inglott; Yasar Yousafzai; Mike Hubank; Christina Halsey
Journal:  Haematologica       Date:  2017-12-07       Impact factor: 9.941

Review 10.  Protein analysis in human cerebrospinal fluid: Physiological aspects, current progress and future challenges.

Authors:  Andreas F Hühmer; Roger G Biringer; Heidi Amato; Alfred N Fonteh; Michael G Harrington
Journal:  Dis Markers       Date:  2006       Impact factor: 3.434

View more
  3 in total

1.  When the bond breaks - targeting adhesion of leukemia cells to the meninges.

Authors:  Lennart Lenk; Fotini Vogiatzi; Denis M Schewe
Journal:  Haematologica       Date:  2020-08       Impact factor: 9.941

2.  CD99 antibody disrupts T-cell acute lymphoblastic leukemia adhesion to meningeal cells and attenuates chemoresistance.

Authors:  Maryam Ebadi; Leslie M Jonart; Jason Ostergaard; Peter M Gordon
Journal:  Sci Rep       Date:  2021-12-21       Impact factor: 4.379

Review 3.  Metabolic Reprogramming and Cell Adhesion in Acute Leukemia Adaptation to the CNS Niche.

Authors:  Nitesh D Sharma; Esra'a Keewan; Ksenia Matlawska-Wasowska
Journal:  Front Cell Dev Biol       Date:  2021-12-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.